About the Journal

Cardiovascular Disease Prevention and Control is a prestigious international, peer - reviewed, open - access journal committed to advancing the understanding and management of cardiovascular diseases from a preventive perspective. In an era where cardiovascular diseases remain a leading global health burden, this journal serves as a vital platform for researchers, clinicians, public health professionals, and policymakers to share knowledge, exchange ideas, and collaborate on innovative strategies to prevent and control these life - threatening conditions.

The journal upholds the highest standards of academic rigor and integrity. All submitted manuscripts undergo a rigorous peer - review process by a panel of international experts in the field of cardiovascular disease prevention and control. This ensures that only high - quality, scientifically sound research is published, contributing to the advancement of knowledge and the improvement of patient outcomes. By providing open access to its content, the journal aims to disseminate research findings widely, enabling researchers and practitioners from diverse backgrounds and regions to access and utilize the latest information in their work.

 

Heart Failure and Cardiac Remodeling

  • Systolic heart failure (HFrEF) and diastolic heart failure (HFpEF): Mechanisms, diagnosis, and novel therapies
  • Cardiac remodeling: Molecular, cellular, and structural adaptations in response to injury
  • Ventricular assist devices (VADs) and mechanical circulatory support

Arrhythmias and Electrophysiology

  • Basic and clinical cardiac electrophysiology: Ion channel disorders, conduction abnormalities, and arrhythmogenesis
  • Management of atrial fibrillation, ventricular tachycardia, and other supraventricular/ventricular arrhythmias
  • Catheter ablation, pacemakers, and implantable cardioverter-defibrillators (ICDs)

Vascular Biology and Atherosclerosis

  • Mechanisms of endothelial dysfunction, plaque formation, and vascular inflammation
  • Hyperlipidemia and lipoprotein metabolism: Implications for atherosclerosis prevention
  • Coagulation and thrombosis: From basic science to antithrombotic therapies

Hypertension and Diabetic Cardiovascular Disease

  • Pathophysiology and treatment of hypertension, including resistant hypertension
  • Diabetic cardiovascular complications: Microvascular and macrovascular disease mechanisms
  • Lifestyle and pharmacological interventions for blood pressure and glycemic control

Structural Heart Disease and Valvular Interventions

  • Aortic stenosis, mitral regurgitation, and other valvular heart diseases
  • Transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair/replacement
  • Cardiac catheterization techniques for structural heart disease diagnosis and treatment

Prevention and Risk Factor Modification

  • Population-level strategies for CVD prevention (e.g., smoking cessation, diet, physical activity)
  • Pharmacological and non-pharmacological interventions for primary and secondary prevention
  • Genetic and epigenetic factors influencing CVD susceptibility

Emerging Fields and Translational Research

  • Molecular cardio-biology: Novel biomarkers and therapeutic targets
  • Myocardial regeneration and stem cell therapies
  • Digital health, AI, and wearable technologies in CVD monitoring and management